Detalhe da pesquisa
1.
Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells.
Front Immunol
; 14: 1227572, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965326